Drug Shortage Report for MANERIX
Report ID | 106249 |
Drug Identification Number | 02166747 |
Brand name | MANERIX |
Common or Proper name | MANERIX |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MOCLOBEMIDE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 tab |
ATC code | N06AG |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-01-24 |
Estimated end date | |
Actual end date | 2021-03-30 |
Shortage status | Resolved |
Updated date | 2021-04-01 |
Company comments | delay in production |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2020-05-28 | French | Compare |
v13 | 2020-05-28 | English | Compare |
v12 | 2020-05-07 | French | Compare |
v11 | 2020-05-07 | English | Compare |
v10 | 2020-04-23 | French | Compare |
v9 | 2020-04-23 | English | Compare |
v8 | 2020-04-09 | French | Compare |
v7 | 2020-04-09 | English | Compare |
v6 | 2020-03-18 | French | Compare |
v5 | 2020-03-18 | English | Compare |
v4 | 2020-03-05 | French | Compare |
v3 | 2020-03-05 | English | Compare |
v2 | 2020-02-14 | French | Compare |
v1 | 2020-02-14 | English | Compare |